Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
IRIX [NASD]
IRIDEX Corporation
Index- P/E43.44 EPS (ttm)0.18 Insider Own2.60% Shs Outstand9.95M Perf Week1.30%
Market Cap77.81M Forward P/E23.70 EPS next Y0.33 Insider Trans19.38% Shs Float9.37M Perf Month-5.90%
Income1.80M PEG1.45 EPS next Q0.04 Inst Own53.30% Short Float0.11% Perf Quarter-12.92%
Sales39.70M P/S1.96 EPS this Y-9.10% Inst Trans-0.26% Short Ratio0.42 Perf Half Y-27.59%
Book/sh2.67 P/B2.93 EPS next Y65.00% ROA5.50% Target Price12.00 Perf Year31.43%
Cash/sh1.41 P/C5.56 EPS next 5Y30.00% ROE7.10% 52W Range5.30 - 11.00 Perf YTD-23.11%
Dividend- P/FCF59.85 EPS past 5Y17.70% ROI10.40% 52W High-28.91% Beta1.54
Dividend %- Quick Ratio3.50 Sales past 5Y-4.60% Gross Margin48.90% 52W Low47.55% ATR0.28
Employees101 Current Ratio5.10 Sales Q/Q15.70% Oper. Margin5.80% RSI (14)42.66 Volatility2.63% 3.36%
OptionableNo Debt/Eq0.00 EPS Q/Q-44.40% Profit Margin4.50% Rel Volume0.49 Prev Close7.75
ShortableYes LT Debt/Eq0.00 EarningsJul 28 Payout0.00% Avg Volume24.42K Price7.82
Recom1.00 SMA20-2.29% SMA50-5.97% SMA200-8.67% Volume11,856 Change0.90%
03-Jan-07Initiated First Albany Buy $15.50
22-May-14 06:30AM  IRIDEX Announces New Multi-Center Study Data Demonstrates Safety, Durability of Proprietary MicroPulse Technology for Treatment of Glaucoma PR Newswire
06:30AM  IRIDEX Announces New Multi-Center Study Data Demonstrates Safety, Durability of Proprietary MicroPulse Technology for Treatment of Glaucoma
10-May-14 01:04PM  IRIDEX CORP Financials EDGAR Online Financials
01:04PM  IRIDEX CORP Financials
05-May-14 04:36PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
04:36PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report
04-May-14 02:43AM  IRIDEX's CEO Discusses Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
02:43AM  IRIDEX's CEO Discusses Q1 2014 Results - Earnings Call Transcript
01-May-14 05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today
04:32PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:32PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IRIDEX Reports 2014 First Quarter Results PR Newswire
04:05PM  IRIDEX Reports 2014 First Quarter Results
07:34AM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
07:07AM  Q1 2014 IRIDEX Earnings Release - After Market Close CCBN
07:07AM  Q1 2014 IRIDEX Earnings Release - After Market Close
24-Apr-14 04:05PM  IRIDEX Announces First Quarter 2014 Conference Call and Release Date PR Newswire
04:05PM  IRIDEX Announces First Quarter 2014 Conference Call and Release Date
22-Apr-14 06:30AM  IRIDEX Announces Proprietary MicroPulse Technology For Treatment Of Eye Diseases Caused By Diabetes And Age-Related Macular Degeneration Featured On 'American Health Front' Program PR Newswire
06:30AM  IRIDEX Announces Proprietary MicroPulse Technology For Treatment Of Eye Diseases Caused By Diabetes And Age-Related Macular Degeneration Featured On 'American Health Front' Program
10-Apr-14 10:27AM  Low-Priced Stock Buys: New Treatments For Eye Disease, Respiratory Difficulties at Forbes
03-Apr-14 01:04PM  IRIDEX CORP Financials EDGAR Online Financials -5.39%
27-Mar-14 05:19PM  IRIDEX CORP Files SEC form 10-K, Annual Report EDGAR Online
27-Feb-14 09:00PM  IRIDEX Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
09:00PM  IRIDEX Management Discusses Q4 2013 Results - Earnings Call Transcript
05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
04:49PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
04:05PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  IRIDEX Reports 2013 Fourth Quarter Results PR Newswire
07:34AM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
07:07AM  Q4 2013 IRIDEX Earnings Release - After Market Close CCBN
20-Feb-14 04:05PM  IRIDEX Announces Fourth Quarter and Full Year 2013 Conference Call and Release Date PR Newswire
29-Jan-14 05:23PM  IRIDEX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:23PM  IRIDEX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
28-Jan-14 06:30AM  IRIDEX Announces Preliminary Unaudited Revenues For 2013 Fourth Quarter and Year End PR Newswire -5.35%
06:30AM  IRIDEX Announces Preliminary Unaudited Revenues For 2013 Fourth Quarter and Year End
09-Jan-14 06:01AM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
06:01AM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
10-Dec-13 04:57PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:57PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers
28-Nov-13 10:00AM  Accelerated Adoption Of Iridex's MicroPulse Technology Could Lead To 100% Upside at Seeking Alpha
10:00AM  Accelerated Adoption Of Iridex's MicroPulse Technology Could Lead To 100% Upside
13-Nov-13 02:14PM  IRIDEX To Introduce Four New Products At Annual AAO Meeting PR Newswire +8.66%
02:14PM  IRIDEX To Introduce Four New Products At Annual AAO Meeting
08-Nov-13 01:04PM  IRIDEX CORP Financials EDGAR Online Financials
01:04PM  IRIDEX CORP Financials
07-Nov-13 06:30AM  IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales PR Newswire
06:30AM  IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales
06-Nov-13 11:28AM  Iridex - In The Early Innings Of Margin Expansion at Seeking Alpha
11:28AM  Iridex - In The Early Innings Of Margin Expansion
04-Nov-13 04:45PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online +9.95%
04:45PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report
31-Oct-13 08:50PM  IRIDEX Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
08:50PM  IRIDEX Management Discusses Q3 2013 Results - Earnings Call Transcript
05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today
04:30PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:30PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  IRIDEX Reports 2013 Third Quarter Results PR Newswire
07:36AM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
07:07AM  Q3 2013 IRIDEX Earnings Release - After Market Close CCBN
24-Oct-13 04:05PM  IRIDEX Announces Third Quarter 2013 Conference Call and Release Date PR Newswire
26-Sep-13 06:09PM  Nasdaq stocks posting largest volume decreases AP
06:30AM  Upcoming Global Medical Conferences to Feature IRIDEX Proprietary MicroPulse Laser Therapy PR Newswire
24-Sep-13 06:06PM  Nasdaq stocks posting largest volume decreases AP
17-Sep-13 04:05PM  IRIDEX to Present at Craig-Hallum 4th Annual Alpha Select Conference PR Newswire
09-Sep-13 09:49AM  Air T Inc Director Buys 23K Shares and 5 Insider Sales to Note at Wall St. Cheat Sheet
15-Aug-13 01:04PM  IRIDEX CORP Financials EDGAR Online Financials
14-Aug-13 01:00PM  [video] Iridex Eyes BRICs To Laser Ahead at TheStreet
13-Aug-13 09:46AM  KeyCorp CFO Buys 17K Shares and 4 Insider Buys to Note at Wall St. Cheat Sheet
06-Aug-13 04:05PM  IRIDEX to Present at 2013 Wedbush Securities Life Sciences Management Access Conference PR Newswire
05-Aug-13 04:37PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
01-Aug-13 05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
04:51PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
04:05PM  IRIDEX Reports 2013 Second Quarter Results; $9.2 Million Record Q2 Revenue PR Newswire
09:32AM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q2 2013 IRIDEX Earnings Release - After Market Close CCBN
25-Jul-13 04:05PM  IRIDEX Announces Second Quarter 2013 Conference Call and Release Date PR Newswire
09-Jul-13 07:01PM  Nasdaq stocks posting largest volume decreases AP
08-Jul-13 11:31PM  IRIDEX CORP Files SEC form 8-K, Other Events EDGAR Online
28-Jun-13 06:06PM  Nasdaq stocks posting largest volume decreases AP
27-Jun-13 06:04PM  Nasdaq stocks posting largest volume decreases AP
26-Jun-13 06:03PM  Nasdaq stocks posting largest volume decreases AP
17-Jun-13 09:11AM  IRIDEX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events EDGAR Online
11-Jun-13 04:06PM  InPlay: IRIDEX announces automatic conversion of series a preferred stock to common stock Briefing.com
04:05PM  IRIDEX Announces Automatic Conversion of Series A Preferred Stock to Common Stock PR Newswire
01:21PM  Nasdaq stocks posting largest percentage decreases AP
10-Jun-13 06:04PM  Nasdaq stocks posting largest percentage decreases AP -5.52%
01:19PM  Nasdaq stocks posting largest percentage decreases AP
31-May-13 10:12AM  Iridex Corporation Stock Downgraded (IRIX) at TheStreet
16-May-13 03:59PM  Ophthalmology Innovators: Will InSite Follow Recent Successes? at Seeking Alpha
06:00AM  IRIDEX Receives Final $510,000 From Sale Of Aesthetic Business Unit PR Newswire
11-May-13 01:04PM  IRIDEX CORP Financials EDGAR Online Financials
06-May-13 09:06AM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
03-May-13 08:10PM  IRIDEX's CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
02-May-13 05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN +6.09%
04:05PM  IRIDEX Reports 2013 First Quarter Results PR Newswire
09:34AM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q1 2013 IRIDEX Earnings Release - After Market Close CCBN
IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases worldwide. Its ophthalmology products consist of laser consoles, such as visible (yellow) photocoagulator console, infrared photocoagulator consoles, micropulse enabled consoles, and multi-wavelength laser system configurations. The company also provides ophthalmic delivery devices and other products, such as TxCell scanning laser delivery systems; TruFocus laser indirect ophthalmoscopes; slit lamp adapters; and operating microscope adapters. In addition, it offers EndoProbe, a fiber optic delivery device used for endophotocoagulation, a retinal treatment procedure; G-Probe, a sterile consumable multi-use product used in procedures to treat medically and surgically uncontrolled glaucoma; and DioPexy Probe, a hand-held instrument used in procedures to treat retinal tears. Further, the company provides GreenTip Soft Tip Cannula, a sterile disposable product, which allows surgeons to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier that provides humidified air to the eye during fluid air exchange. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It sells and markets its products through a direct sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mackaness James HCFO and COOJul 21Option Exercise4.311,0004,3103,000Jul 23 06:42 PM
Mackaness James HCFO and COOJul 21Sale7.621,0007,6152,000Jul 23 06:42 PM
FITCH SANFORDDirectorJul 14Option Exercise2.465,00012,30035,344Jul 15 06:40 PM
Mackaness James HCFO and COOJun 23Option Exercise0.902,0001,8003,000Jun 24 07:08 PM
Mackaness James HCFO and COOJun 23Sale8.242,00016,4882,000Jun 24 07:08 PM
Steckel RonaldVP, OperationsJun 17Option Exercise3.941,6506,5002,989Jun 18 06:21 PM
Steckel RonaldVP, OperationsJun 17Sale8.201,65013,5351,964Jun 18 06:21 PM
FITCH SANFORDDirectorJun 06Option Exercise5.265,00026,3005,000Jun 09 06:51 PM
BlueLine Catalyst Fund IX, L.PDirectorJun 06Buy8.327,39061,4852,517,533Jun 09 04:44 PM
FITCH SANFORDDirectorJun 06Sale8.395,00041,9500Jun 09 06:51 PM
MOORE WILLIAM MChairman and CEOJun 03Buy8.485,00042,40082,396Jun 04 05:17 PM
Mackaness James HCFO and COOMay 21Option Exercise0.903,0002,7003,000May 22 06:52 PM
Mackaness James HCFO and COOMay 21Sale8.733,00026,1892,000May 22 06:52 PM
Steckel RonaldVP, OperationsMay 19Option Exercise3.941,6506,5002,989May 20 04:53 PM
Steckel RonaldVP, OperationsMay 19Sale8.821,65014,5451,964May 20 04:53 PM
MOORE WILLIAM MChairman and CEOMay 09Buy8.405,00042,00078,944May 13 04:58 PM
Mackaness James HCFO and COOApr 22Option Exercise0.901,0009003,000Apr 23 06:28 PM
Mackaness James HCFO and COOApr 22Sale9.001,0009,0002,000Apr 23 06:28 PM
Mackaness James HCFO and COOApr 21Option Exercise0.903,0002,7004,000Apr 23 06:28 PM
Mackaness James HCFO and COOApr 21Sale8.653,00025,9562,000Apr 23 06:28 PM
Steckel RonaldVP, OperationsApr 17Option Exercise3.941,6506,5002,989Apr 21 06:24 PM
Steckel RonaldVP, OperationsApr 17Sale8.881,65014,6521,964Apr 21 06:24 PM
Mackaness James HCFO and COOMar 21Option Exercise0.904,0003,6003,000Mar 24 08:20 PM
Mackaness James HCFO and COOMar 21Sale9.034,00036,1392,000Mar 24 08:20 PM
Steckel RonaldVP, OperationsMar 17Option Exercise3.941,6506,5002,275Mar 19 07:50 PM
Steckel RonaldVP, OperationsMar 17Sale9.071,65014,9661,250Mar 19 07:50 PM
GARRETTSON GARRETT ADirectorMar 04Option Exercise6.3911,25071,88841,049Mar 06 05:59 PM
GARRETTSON GARRETT ADirectorMar 04Sale9.224,99346,05436,056Mar 06 05:59 PM
GARRETTSON GARRETT ADirectorFeb 27Option Exercise5.265,00026,30030,899Feb 27 09:11 PM
Steckel RonaldVP, OperationsFeb 18Option Exercise3.941,6506,50036,850Feb 19 05:26 PM
Steckel RonaldVP, OperationsFeb 18Sale8.601,65014,19022,625Feb 19 05:26 PM
Steckel RonaldVP, OperationsJan 17Option Exercise3.941,6506,50037,875Jan 21 05:57 PM
Steckel RonaldVP, OperationsJan 17Sale10.421,65017,19323,250Jan 21 05:57 PM
Steckel RonaldVP, OperationsDec 17Option Exercise3.941,6506,50038,900Dec 18 04:44 PM
Steckel RonaldVP, OperationsDec 17Sale8.561,65014,12423,875Dec 18 04:44 PM
Mackaness James HCFO and COODec 02Option Exercise2.4910,00024,90010,000Dec 03 04:35 PM
Mackaness James HCFO and COODec 02Sale10.5210,000105,2180Dec 03 04:35 PM
Steckel RonaldVP, OperationsNov 18Option Exercise3.941,6506,50039,925Nov 20 04:18 PM
Steckel RonaldVP, OperationsNov 18Sale8.691,65014,33924,500Nov 20 04:18 PM
Mackaness James HCFO and COONov 06Option Exercise2.4910,00024,90025,000Nov 08 04:25 PM
Mackaness James HCFO and COONov 06Sale8.3510,00083,49615,000Nov 08 04:25 PM
NAUMANN-ETIENNE RUEDIGERDirectorSep 06Buy5.992,58415,47859,899Sep 06 04:16 PM
NAUMANN-ETIENNE RUEDIGERDirectorSep 05Buy5.991,0015,99657,315Sep 06 04:16 PM
NAUMANN-ETIENNE RUEDIGERDirectorSep 04Buy5.90158956,314Sep 06 04:16 PM
MOORE WILLIAM MChairman and CEOAug 09Buy5.889,80057,64477,396Aug 12 04:41 PM
MOORE WILLIAM MChairman and CEOAug 08Buy5.802001,16067,596Aug 12 04:41 PM